Lataa...
Smart CARs Engineered for Cancer Immunotherapy
PURPOSE: Chimeric antigen receptors (CARs) are synthetic immunoreceptors that can redirect T cells to selectively kill tumor cells, and as “living-drugs” have the potential to generate long-term anti-tumor immunity. Given their recent clinical successes for the treatment of refractory B-cell maligna...
Tallennettuna:
| Julkaisussa: | Curr Opin Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4659816/ https://ncbi.nlm.nih.gov/pubmed/26352543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000232 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|